glp-1 receptor agonist news Muscle Loss Explained GLP-1 Receptor Agonist Market Size

doi: 10.3390/nu15092150

Epitalon is a synthetic tetrapeptide studied for its mechanisms related to cellular function and molecular regulation

The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts

By inducing the expression and activity of HO-1, it can enhance the antioxidant, anti-inflammatory, and anti-apoptotic capacity of tissues, and thus reduce the degree of damage in diabetic complications

Are you thinking green